Overview
BMRN market data
Price History
BMRN price chart · 1M
- O
- 66.06
- H
- 66.64
- L
- 65.87
- C
- 66.55
- Vol
- 49,593.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $66.06
- Previous Close
- $66.43
- Day High
- $66.64
- Day Low
- $65.87
- 52 Week High
- $70.98
- 52 Week Low
- $49.29
- 7 Day Return
- +2.95%
- 30 Day Return
- +11.07%
- 90 Day Return
- +17.62%
- 1 Year Return
- +26.57%
- Daily Notional Volume
- $3.3M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 176.01 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $1.77 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.20 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 2.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $49.26 – $70.98 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $12.8B · P/B 1.88 · P/S 3.77.
Company News
10 captured
How BioMarin Turned a Competitive Threat Into a Royalty-Bearing AssetZacks Investment Research ·
HC Wainwright & Co. Maintains Neutral on BioMarin Pharmaceutical, Raises Price Target to $60Benzinga ·